Chemical Compound

salinomycin

CAS Registry Number 53003-10-4
Back to search Request a Quote
salinomycin chemical structure
Primary Record

salinomycin

In stock
8,609 g
Purity
98.5 %
CAS
53003-10-4

Compound Identifiers & Properties

CAS
53003-10-4
PubChem CID
3085092
SMILES
CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O
Canonical SMILES
CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C

Names & Synonyms

  • salinomycin
  • Procoxacin
  • Coxistac
  • Salinomicina
  • Salinomycine
  • Salinomycinum
  • 53003-10-4
  • Bio-cox
  • Procoxacin (TN)
  • Salinomycin Mycelia
  • Salinomycin (INN)
  • KOKCISAN
  • Antibiotic 61477
  • Salinomycin [INN:BAN]
  • RefChem:57321
  • Salinomycine [INN-French]
  • Salinomycinum [INN-Latin]
  • Salinomycin (Procoxacin)
  • AC1MJ3UE
  • Salinomicina [INN-Spanish]
  • Salinomycin [BAN:INN]
  • SALINOMYCIN [MI]
  • Salinomycin Sodium Premix
  • SALINOMYCIN [INN]
  • SALINOMYCIN [JAN]
  • salinomycin monosodium salt
  • DTXSID4048486
  • SALINOMYCIN [HSDB]
  • SALINOMYCIN, SODIUM
  • UNII-62UXS86T64
  • KQXDHUJYNAXLNZ-XQSDOZFQSA-N
  • 62UXS86T64
  • SCHEMBL36890
  • HSDB 7032
  • C42H69NaO11
  • MFCD25541652
  • orb1710669
  • AHR 3096
  • CHEMBL1208572
  • DTXCID4028460
  • CHEBI:80025
  • EINECS 258-290-1
  • GTPL11088
  • C42H70O11
  • BDBM430647
  • HMS6018M13
  • BBF-03447
  • MSK000595
  • NSC757437
  • s2352
  • ZINC85540254
  • K 364
  • AKOS030526154
  • CCG-208535
  • CID3085092
  • CS-1299
  • DB11544
  • EBC-454735
  • J3.516E
  • MSK000595-100M
  • NSC-757437
  • C42-H70-O11
  • CID:3085092
  • MSK000595-1000M
  • BS-17023
  • E716
  • HY-15597
  • SID:53786922
  • SY252444
  • A3785
  • FT-0630657
  • NS00007817
  • Salinomycin Solution in Methanol, 100ug/mL
  • Salinomycin Solution in Methanol, 1000ug/mL
  • C15690
  • D08502
  • W-6068
  • A829344
  • C010327
  • Q411909
  • SR-05000002207
  • SR-05000002207-3
  • Salinomycin, from Streptomyces albus, >=98% (HPLC)
  • (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid
  • Salinomycin, Ready Made Solution, from Streptomyces albus, >=98% (HPLC)
  • (2R)-2-((2R,5S,6R)-6-((2S,3S,4S,6R)-6-((3S,5S,7R,9S,10S,12R,15R)-3-((2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl)-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro(4.1.57.35)pentadec-13-en-9-yl)-3-hydroxy-4-methyl-5-oxooctan-2-yl)-5-methyloxan-2-yl)butanoic acid
  • (2R)-2-[(2R,5S,6R)-6-[(1S,2S,3S,5R)-5-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyl-tetrahydropyran-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-2-hydroxy-1,3-dimethyl-4-oxo-heptyl]-5-methyl-tetrahydropyran-2-yl]butanoic acid
  • (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5?.3?]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid
  • (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid
  • (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid
  • (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid
  • (2R)-2-{(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-{(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-Ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5~7~.3~5~]pentadec-13-en-9-yl}-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl}butanoic acid
  • (alphaR,2R,5S,6R)-alpha-ethyl-6-((1S,2S,3S,5R)-5-((2S,5S,7R,9S,10S,12R,15R)-2-((2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxydispiro(4.1.5.3)-pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)-tetrahydro-5-methyl-2H-pyran-2-acetic acid
  • (R)-2-((2R,5S,6R)-6-((2S,3S,4S,6R)-6-((2S,5S,7R,9S,10S,12R,15R)-2-((2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl)-3-hydroxy-4-methyl-5-oxooctan-2-yl)-5-methyltetrahydro-2H-pyran-2-yl)butanoic acid
  • (R)-2-((2R,5S,6R)-6-((2S,3S,4S,6R)-6-((2S,5S,7R,9S,10S,12R,15R)-2-((2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl)-3-hydroxy-4-methyl-5-oxooctan-2-yl)-5-methyltetrahydro-2H-pyran-2-yl)butanoicacid
  • 1,6,8-Trioxadispiro[4.1.5.3]pentadecane, salinomycin deriv.; Antibiotic 61477; Coxistac; Stereoisomer of a-ethyl-6-[5-[2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl]-2-hydroxy-1,3-dimethyl-4-oxoheptyl]tetrahydro-5-methyl-2H-pyran-2-acetic acid; Salinomycin
  • 258-290-1